UBS Maintains Neutral on Xometry, Raises Price Target to $95

Benzinga Newsdesk www.benzinga.com Neutral 50.2%

Neg 0% Neu 50.2% Pos 0%

UBS analyst Joshua Chan maintains Xometry (NASDAQ:XMTR) with a Neutral and raises the price target from $88 to $95.

Comments

No comments yet. Be the first!